Mark Reglinski

621 total citations
17 papers, 408 citations indexed

About

Mark Reglinski is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Mark Reglinski has authored 17 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 8 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Mark Reglinski's work include Streptococcal Infections and Treatments (11 papers), Neonatal and Maternal Infections (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Mark Reglinski is often cited by papers focused on Streptococcal Infections and Treatments (11 papers), Neonatal and Maternal Infections (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Mark Reglinski collaborates with scholars based in United Kingdom, United States and Sweden. Mark Reglinski's co-authors include Shiranee Sriskandan, Nicola N. Lynskey, Robert J. Edwards, Jeremy Brown, Fernanda C. Petersen, Matthew K. Siggins, Marina Botto, Damien Calay, Justin C. Mason and Claire E. Turner and has published in prestigious journals such as The EMBO Journal, Scientific Reports and Molecular Microbiology.

In The Last Decade

Mark Reglinski

17 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Reglinski United Kingdom 10 194 171 130 84 73 17 408
Nicola N. Lynskey United Kingdom 11 354 1.8× 250 1.5× 102 0.8× 58 0.7× 38 0.5× 18 464
Kristin R. Wade United States 11 153 0.8× 101 0.6× 125 1.0× 140 1.7× 69 0.9× 11 412
Sudha R. Somarajan United States 10 59 0.3× 112 0.7× 137 1.1× 134 1.6× 126 1.7× 14 378
D. Patric Nitsche-Schmitz Germany 13 309 1.6× 208 1.2× 116 0.9× 85 1.0× 34 0.5× 23 421
Katherine J. Kasper Canada 13 219 1.1× 271 1.6× 94 0.7× 113 1.3× 50 0.7× 18 532
Carla Emolo United States 10 173 0.9× 251 1.5× 169 1.3× 277 3.3× 153 2.1× 10 512
Eugene H. Burns United States 8 334 1.7× 275 1.6× 75 0.6× 70 0.8× 53 0.7× 10 443
Andreas Berge Sweden 10 462 2.4× 346 2.0× 204 1.6× 64 0.8× 33 0.5× 22 642
Laura Masala Italy 10 215 1.1× 145 0.8× 259 2.0× 159 1.9× 119 1.6× 12 518
Annalisa Colaprico Italy 7 135 0.7× 124 0.7× 137 1.1× 114 1.4× 64 0.9× 7 399

Countries citing papers authored by Mark Reglinski

Since Specialization
Citations

This map shows the geographic impact of Mark Reglinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Reglinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Reglinski more than expected).

Fields of papers citing papers by Mark Reglinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Reglinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Reglinski. The network helps show where Mark Reglinski may publish in the future.

Co-authorship network of co-authors of Mark Reglinski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Reglinski. A scholar is included among the top collaborators of Mark Reglinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Reglinski. Mark Reglinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ndeh, Didier, Helen Alexandra Shaw, Sarah Thomson, et al.. (2025). Recombinant production platform for Group A Streptococcus glycoconjugate vaccines. npj Vaccines. 10(1). 16–16. 2 indexed citations
2.
Reglinski, Mark, David J. Williams, Marek Gierliński, et al.. (2025). A widely-occurring family of pore-forming effectors broadens the impact of the Serratia Type VI secretion system. The EMBO Journal. 44(23). 6892–6918. 2 indexed citations
3.
Reglinski, Mark, Laura Monlezun, & Sarah J. Coulthurst. (2023). The accessory protein TagV is required for full Type VI secretion system activity in Serratia marcescens. Molecular Microbiology. 119(3). 326–339. 5 indexed citations
4.
Pearson, Max, Carl Haslam, Andrew Fosberry, et al.. (2023). Structure–activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal. Scientific Reports. 13(1). 19052–19052. 1 indexed citations
5.
Tan, Lionel, Mark Reglinski, Lucy Lamb, et al.. (2021). Vaccine-induced, but not natural immunity, against the Streptococcal inhibitor of complement protects against invasive disease. npj Vaccines. 6(1). 62–62. 8 indexed citations
6.
Reglinski, Mark, Shiranee Sriskandan, & Claire E. Turner. (2019). Identification of two new core chromosome-encoded superantigens in Streptococcus pyogenes; speQ and speR. Journal of Infection. 78(5). 358–363. 16 indexed citations
7.
Reglinski, Mark & Shiranee Sriskandan. (2019). Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin. BMC Research Notes. 12(1). 228–228. 4 indexed citations
8.
Reglinski, Mark, Giuseppe Ercoli, Emily J. Kay, et al.. (2018). A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13. npj Vaccines. 3(1). 53–53. 42 indexed citations
9.
Wilson, Robert, Jonathan Cohen, Mark Reglinski, et al.. (2017). Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens. PLoS Pathogens. 13(1). e1006137–e1006137. 67 indexed citations
10.
Lynskey, Nicola N., Mark Reglinski, Damien Calay, et al.. (2017). Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase. PLoS Pathogens. 13(8). e1006493–e1006493. 56 indexed citations
11.
Reglinski, Mark, Nicola N. Lynskey, & Shiranee Sriskandan. (2016). Modification of the classical Lancefield assay of group A streptococcal killing to reduce inter-donor variation. Journal of Microbiological Methods. 124. 69–71. 5 indexed citations
12.
Reglinski, Mark, Nicola N. Lynskey, Yoon Jung Choi, Robert J. Edwards, & Shiranee Sriskandan. (2016). Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG. Journal of Infection. 72(4). 450–459. 32 indexed citations
13.
Reglinski, Mark, Magdalena Gierula, Nicola N. Lynskey, Robert J. Edwards, & Shiranee Sriskandan. (2015). Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulin. Scientific Reports. 5(1). 15825–15825. 27 indexed citations
14.
Lynskey, Nicola N., Suneale Banerji, Louise A. Johnson, et al.. (2015). Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via Lymphatic Vessel Endothelial Receptor-1 Interaction. PLoS Pathogens. 11(9). e1005137–e1005137. 36 indexed citations
15.
Reglinski, Mark & Shiranee Sriskandan. (2013). The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis. Virulence. 5(1). 127–136. 41 indexed citations
16.
Bannoehr, Jeanette, Nouri L. Ben Zakour, Mark Reglinski, et al.. (2011). Genomic and Surface Proteomic Analysis of the Canine Pathogen Staphylococcus pseudintermedius Reveals Proteins That Mediate Adherence to the Extracellular Matrix. Infection and Immunity. 79(8). 3074–3086. 54 indexed citations
17.
Reglinski, Mark, et al.. (1978). Ex-vivo removal of mammalian immunoglobulin G: method and immunological alterations.. PubMed. 1(2). 94–103. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola N. Lynskey Breakdown of academic impact, for papers by Kristin R. Wade Breakdown of academic impact, for papers by Sudha R. Somarajan Breakdown of academic impact, for papers by D. Patric Nitsche-Schmitz Breakdown of academic impact, for papers by Katherine J. Kasper Breakdown of academic impact, for papers by Carla Emolo Breakdown of academic impact, for papers by Eugene H. Burns Breakdown of academic impact, for papers by Andreas Berge Breakdown of academic impact, for papers by Laura Masala Breakdown of academic impact, for papers by Annalisa Colaprico
Rankless by CCL
2026